Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Return on Capital Employed (2021 - 2025)

Kezar Life Sciences' Return on Capital Employed history spans 5 years, with the latest figure at 0.72% for Q1 2025.

  • For Q1 2025, Return on Capital Employed fell 15.0% year-over-year to 0.72%; the TTM value through Mar 2025 reached 0.72%, down 15.0%, while the annual FY2023 figure was 0.46%, 17.0% down from the prior year.
  • Return on Capital Employed for Q1 2025 was 0.72% at Kezar Life Sciences, down from 0.68% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.22% in Q3 2022 and bottomed at 0.72% in Q1 2025.
  • The 5-year median for Return on Capital Employed is 0.35% (2023), against an average of 0.42%.
  • The largest annual shift saw Return on Capital Employed rose 8bps in 2022 before it dropped -28bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.33% in 2021, then increased by 26bps to 0.24% in 2022, then tumbled by -110bps to 0.51% in 2023, then crashed by -33bps to 0.68% in 2024, then dropped by -5bps to 0.72% in 2025.
  • Per Business Quant, the three most recent readings for KZR's Return on Capital Employed are 0.72% (Q1 2025), 0.68% (Q3 2024), and 0.62% (Q2 2024).